(NTX) and asinopterin are both subject to hydruxylation aL the 7-position of the pteridine ring. This is sT considerable clinical importance as by 12 h after HTX the levels of 7-OH-MTX can he lB-2B Limes higher than those of the parent compound. The 7-OSseLabnlite is lEE-lEES Told less effective, but competes uith RTX for transport into the cells. The 8-deaza-analogues of MTX and aminupterin are not hydruxylated at the 7-position. This could be demunstrafed by incubating the compounds uith partially puriTied rabbit liver aldehyde oxidase, an enzyme that converted the same amounts oT MTX ur aminopterin under the same conditions quantitavely to the 7-OH-meLabulite. In cosparisun to their parent compounds, the potential of gruuth inhibition in cell cultures mas found slightly increased (i. The combination of the brachy-therapy and teletherapy makes necessary some considerations in relation to localization, volume-factor, time-factor, dose-weighing, and superposition of effective doses.
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PHYSICAL AND RADIOBIOLOGICAL BASIS OF THE CO~IHATION OF INTERSTITIAL AND PERCUTANHOUS RADIOTHERAPY R.G.M~ller W, H.-J.Thiel we, R.Sauer ew
The combination of the brachy-therapy and teletherapy makes necessary some considerations in relation to localization, volume-factor, time-factor, dose-weighing, and superposition of effective doses.
While the medical localization of the tumour, the physical calculation of the dose distributions, and the spatial fitting of them can be managed fairly exactly, assisted by CT if possible, the biological weighing of the dose after different therapeutic regimes still makes problems.
Our thesis is, that all dose-effect-relations the radiotherapists are using today are proper for dose rates down to 30 rd/h only. In case of the application of lower dose rates -e.g. 1-215 or Ir-192 permanent implants -the cell or tumour kinetics have to be taken into account. The treatment over more and more cell cycles enhances the biological effectiveness, which can be shown by an experimental based mathematical system. Brachytherapy can be classified in terms of the dose-rate into three categories: high-, medium and low dose-rate treatments. Because of the very different dose-rates which vary by a factor of 10 to 100 between the various treatment modalities completely different radiation protection problems arise. Also the demand of the equipment is quite distinct. Common to all of them is the need for~care-full quality assurance program. a) High dose-rate brachytherapy Because of the high dose-rates used the treatment has to be performed in a remote afterloading technique. Radiation protection of the personel] is achieved by a shielded treatment room. The demand for the equipment is highly sophisticated and has to fulfill DIN 6853. Treatment planning is complicated because of the short duration of the whole procedure and has to be performed in advance. The use of templates for interstitial treatments is indicated. b) Medium dose-rate brachytherapy From the radiation protection point of view this kind of therapy gives the biggest problems. Although the doserates around the patient is quite moderate the staff has to spend some time close to the patient for care purposes Manually afterloading permits an exact therapy planning and a reduction of radiation exposure to the operating staff. c) Low dose-rate brachytherapy Mainly J-125-seeds are used for this purpose. The dose-rates in I m distance of the patient are in the range of 0,5 -5,0 uSv/h depending on the amount of activity applied and its position within the patient. The very low kV-radiation of J-125 can easily be shielded. Prognosis of locally advanced head and neck carcinomas is poor despite the use of aggressive surgical resection and/ or radiation treatment. Due to local extension and frequent regional spread, recurrences especially concerning tumors of the naso-oro-and hypopharynx as well as the oral cavity (oral tonque, floor of the mouth) are an important cause of treatment failure. The results of retreating local recurrences following surgery and/or external radiation therapy are even poorer than in primary treatment. Apart from surgery, external radiotherapy or chemotherapy, interstitial radioactive implants maybe indicated n case of relapse, even if such patients are irradiated for palliation rather than for curative purposes. This method enables the delivery of a high dose to a limited volume without unacceptable toxicity to neighboring structures. For treatment we used either low-dose-rate 125 J-seeds in carrier (Vicryl) or the high-dose-rate 192 Ir-afterloading system. Regarding radiation protection the afterloading technique is superior for the medical stuff. For most of our patients at least a partial regression of the tumormass could be observed combined with improvement of symptoms. However the follow-up was short since most of the patients died within several months of the treatment. Nevertheless interstitial radiotherapy offers good palliation for patients with recurrent head and neck cancer and may also h~ usefull in the definitive management of locally advanced disease as adjunct to external radiation therapy.
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